Apr 16, 2012 09:00 BST Gambro introduces SelectBag® Citrate to improve quality of life for hemodialysis patients. Improving quality of life for hemodialysis patients is a primary goal of the innovative new SelectBag® Citrate concentrate from Gambro — the unique citrate-containing, acetate-free dialysis fluid for regular hemodialysis and hemodiafiltration treatment.

Feb 06, 2012 09:01 GMT A research consortium headed by Gambro in Germany, consisting of researchers from different disciplines, has received a project grant of 2.1 million euros from the German Federal Ministry of Education and Research. The project aims to investigate a new generation of dialysis membranes to improve the treatment of chronic inflammation in End Stage Renal Disease patients.

Oct 06, 2011 13:12 BST Effective CRRT is largely determined by adequate anticoagulation of the extracorporeal circuit. With FleXitrate, Gambro makes performing regional citrate anticoagulation simple and safe.

Jul 15, 2011 10:00 BST It all started in 1984, with the production of single lumen catheters. Today, more than 70 employees work at Gambro Kathetertechnik in Hechingen, which recently celebrated 25 years of catheter production.

Jul 05, 2011 10:00 BST On June 24, 2011, Gambro hosted a Lunch Symposium at the ERA-EDTA Congress in Prague which attracted great interest from the Congress delegates. The main topic discussed was different therapy options for individualized quality-assured dialysis.

Jun 08, 2011 16:47 BST On June 1st, Gambro signed an agreement with Italian Trade Union representatives at the Italian Ministry of Economic Development (Ministero dello Sviluppo Economico) to continue with the optimization of the bloodline manufacturing foot print as announced on January 27, 2011.

May 23, 2011 16:48 BST As part of the ongoing work to make Gambro more efficient and cost effective, a decision has been made to move the Gambro headquarters from Stockholm to Lund, Sweden.

Apr 06, 2011 16:37 BST Gambro is donating 10M Japanese Yen, equivalent of app. 720 000 SEK, to the Japanese Red Cross as part of its continued support to the people of Japan during this time of crisis.

Jan 27, 2011 12:51 GMT Gambro today announces its decision to cease bloodline manufacturing in Medolla, Italy, in order to optimize its global bloodline manufacturing footprint. The company has decided to outsource a number of the bloodline manufacturing activities currently performed at the site, and to consolidate the remaining bloodline activities into its manufacturing sites in Přerov, Shanghai and Tijuana.

Dec 27, 2010 12:57 GMT Gambro today announced it has finalized* the sale of its global peritoneal dialysis (PD) business to Fresenius Medical Care. The ownership of Gambro’s solutions manufacturing plant in Canosa, Italy will coincide with the transfer of the manufacturing license expected to occur in early 2011.